Safety of the propofol-dexmedetomidine-fentanyl combination compared with the propofol-fentanyl combination for deep sedation during ERCP: A randomized, controlled trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026106

Enrollment

Unknown

Registered

2019-09-21

Start date

2019-10-01

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatobiliary and pancreatic disease

Interventions

Group 2:propofol-dexmedetomidine-fentanyl protocol

Group 1:propofol-fentanyl protocol

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for elective ERCP; 2. Aged 18 to 75 years old; 3. American Society of Anesthesiologists (ASA) grades I-III.

Exclusion criteria

Exclusion criteria: 1. Patients with a known allergy to the study drugs 2. Pregnancy; 3. Anticipated difficult airway.

Design outcomes

Primary

Measure	Time frame
HR;MAP;RR;SpO2;	—

Secondary

Measure	Time frame
PONV;Intraoperative body movement;Shivering;Coughing;Breath holding;Airway assistance;	—

Countries

China

Contacts

Public ContactYe Yuan

The First Hospital of Jilin University

yeyuan1225@sina.com+86 13604430557

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026